190618 Implications of fear as a public health issue

Tuesday, October 28, 2008: 11:30 AM

Kirk Koyama, MSN, RN, CNS , Indian Health Services, Chinle Comprehensive Health Care Facility, Chinle, AZ
This presentation reviews how the use of fear has significantly impacted the effectiveness of public health interventions nationally and internationally, especially among bordering nations.

The possible political and professional consequences of using fear to drive public health initiatives, both nationally and internationally, will be addressed.

An ecological and grounded theoretical approach, using constant comparisons, offers a challenging call for improved collaborative efforts among public health researchers, health care professionals, and human rights organizations, with special emphasis on retrospective, in-depth interviews and population-based surveys.

This presentation explores both short-term and long-term implications of how the use of fear has become a public health issue through cases studies. It will describe the need for public health research, the importance of collaboration and partnerships, the implications of taking no action on future health initiatives, the impact of changes in the future health care workforce, and outline future research scenarios.

Learning Objectives:
Recognize the impact of fear as a public health issue. Identify actions that public health workers can take to dispel fear as a public health issue for individuals, families, and community organizations. Discuss how fear can advance or impede public health issues. Explore ways of improving partnerships and opportunities for public health workers to reduce barriers such as stigma and fear and help improve the health outcomes for at-risk populations.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am the author of this presentation
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.